EPIX Pharmaceuticals, Inc. Contracts & Agreements
70 Contracts & Agreements
- Business Finance (23 contracts)
- Business Operations (7)
- Human Resources (22)
- Intellectual Property (5)
- Mergers & Acquisitions (1)
- Real Estate (6)
- Uncategorized (6)
- EX-10.1 Assignment for the Benefit of Creditors dated July 20, 2009 (Filed With SEC on July 21, 2009)
- EX-10.1 Exchange Agreement between the Company and Citigroup Global Markets Inc. dated July 9, 2009 (Filed With SEC on July 10, 2009)
- EX-10.2 Note Purchase Agreement between the Company and Loomis, Sayles & Company, L.P. dated July 9, 2009 (Filed With SEC on July 10, 2009)
- Ex-4.1 Second Supplemental Indenture, dated May 7, 2009, between EPIX Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on May 7, 2009)
- Ex-10.1 Contingent Value Rights Agreement, dated May 7, 2009, between EPIX Pharmaceuticals, Inc. and U.S. Bank National Association, as rights agent (Filed With SEC on May 7, 2009)
- EX-10.1 Employment Agreement by and between the Company and Elkan Gamzu, Ph.D (Filed With SEC on April 9, 2009)
- THIS AGREEMENT IS NOT AN OFFER WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF ANY KIND. SUCH AN OFFER OR SOLICITATION WILL BE MADE ONLY IN COMPLIANCE WITH ALL APPLICABLE... (Filed With SEC on April 7, 2009)
- ASSET PURCHASE AGREEMENT As of April 6, 2009 (Filed With SEC on April 7, 2009)
- between Bayer Schering Pharma AG, Mllerstrae 178,13353 Berlin, Germany (hereinafter referred to as BSP) and EPIX Pharmaceuticals Inc., 4Maguire Rd Lexington, MA 02421, USA... (Filed With SEC on April 7, 2009)
- EX-10.9 INTELLECTUAL PROPERTY AGREEMENT (Filed With SEC on March 13, 2009)
- Ex-10.1 Letter Agreement dated as of March 9, 2009 (Filed With SEC on March 12, 2009)
- EX-10.1 Employment Agreement, dated as of September 15, 2008 (Filed With SEC on September 18, 2008)
- EX-10.2 Amendment to Employment Agreement, dated as of September 16, 2008 (Filed With SEC on September 18, 2008)
- Ex-10.6 Lease, as amended through June 2, 2008 (Filed With SEC on August 7, 2008)
- WARRANT (Filed With SEC on August 5, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 5, 2008)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 5, 2008)
- EX-10.1 Separation Agreement between the Company and Michael G. Kauffman, M.D., Ph.D., dated as of July 25, 2008 (Filed With SEC on July 28, 2008)
- EX-10.2 Letter Agreement between the Company and Elkan Gamzu, Ph.D., dated as of July 25, 2008 (Filed With SEC on July 28, 2008)
- EX-10.1 Employment Agreement between the Company and Chen Schor, dated as of June 16, 2008 (Filed With SEC on June 19, 2008)
- EX-10.1 Separation Agreement and Post-Employment Consulting Agreement (Filed With SEC on June 3, 2008)
- Ex-10.1 2008 Stock Option and Incentive Plan (Filed With SEC on May 21, 2008)
- EX-10.1 Research, Development and Commercialization Agreement between EPIX Pharmaceuticals, Inc. and Cystic Fibrosis Foundation Therapeutics, Inc., dated as of April 1, 2008 (Filed With SEC on May 9, 2008)
- EX-10.6 Amended and Restated Strategic Collaboration Agreement dated as of June 9, 2000 (Filed With SEC on March 17, 2008)
- EX-10.7 Strategic Collaboration Agreement dated as of June 9, 2000 (Filed With SEC on March 17, 2008)
- EX-10.8 Amendment No. 1 dated as of December 22, 2000 to the Strategic Collaboration Agreement (Filed With SEC on March 17, 2008)
- FORM OF RESTRICTED STOCK UNIT AGREEMENT UNDER THE EPIX PHARMACEUTICALS, INC. AMENDED AND RESTATED 1992 INCENTIVE PLAN (Filed With SEC on February 22, 2008)
- FORM OF RESTRICTED STOCK UNIT AGREEMENT UNDER THE EPIX PHARMACEUTICALS, INC. AMENDED AND RESTATED 2003 STOCK INCENTIVE PLAN (Filed With SEC on February 22, 2008)
- EX-10.1 Form of Securities Purchase Agreement dated November 9, 2007 (Filed With SEC on November 15, 2007)
- EX-10.1 THIRD AMENDMENT TO RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on November 7, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2007)
- EX-10.3 Non-Employee Director Compensation Policy (Filed With SEC on August 8, 2007)
- FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on June 15, 2007)
- Ex-10.52 First Amendment to License Agreement between Amgen Inc. and the Company (Filed With SEC on April 10, 2007)
- Ex-10.1 Release Agreement dated April 5, 2007 (Filed With SEC on April 6, 2007)
- EX-10.1 Employment Agreement between the Company and Kimberlee C. Drapkin (Filed With SEC on March 29, 2007)
- EX-10.2 Employment Agreement between the Company and Michael G. Kauffman, M.D., Ph.D (Filed With SEC on March 29, 2007)
- EX-10.1 Development and License Agreement (Filed With SEC on January 18, 2007)
- EX-10.2 Stock Purchase Agreement (Filed With SEC on January 18, 2007)
- Ex-10.1 Release Agreement, dated November 10, 2006 (Filed With SEC on November 13, 2006)
- Ex-4.1 Specimen certificate for Shares of Common Stock (Filed With SEC on November 9, 2006)
- Ex-4.3 Warrant issued to RRD International, LLC (Filed With SEC on November 9, 2006)
- Ex-4.4 Warrant issued to General Electric Capital Corporation (Filed With SEC on November 9, 2006)
- Ex-4.5 Warrant issued to Oxford BioScience Management Partners II (Filed With SEC on November 9, 2006)
- Ex-10.1 Predix Pharmaceuticals Holdings, Inc. Amended and Restated 2003 Stock Incentive Plan (Filed With SEC on November 9, 2006)
- Ex-10.2 Physiome Sciences, Inc. 1997 Stock Option Plan (Filed With SEC on November 9, 2006)
- Ex-10.3 Amended and Restated License Agreement (Filed With SEC on November 9, 2006)
- Ex-10.4 Research Development and Commercialization Agreement (Filed With SEC on November 9, 2006)
- Ex-10.5 License Agreement by and between Predix Pharmaceuticals Holdings, Inc. and Amgen Inc (Filed With SEC on November 9, 2006)
- Ex-10.6 Lease by and between Trustees of 4 Maguire Road Realty Trust and the Predix Pharmaceuticals Holdings, Inc (Filed With SEC on November 9, 2006)
- Ex-10.7 Lease Agreement (Filed With SEC on November 9, 2006)
- Ex-10.8 Sublease Agreement (Filed With SEC on November 9, 2006)
- Ex-10.9 Unprotected Lease Agreement (Filed With SEC on November 9, 2006)
- Ex-10.10 Employment Agreement, Michael G. Kauffman, M.D., Ph.D (Filed With SEC on November 9, 2006)
- Ex-10.11 Employment Agreement, Silvia Noiman, Ph.D (Filed With SEC on November 9, 2006)
- Ex-10.12 Employment Agreement, Kimberlee C. Drapkin (Filed With SEC on November 9, 2006)
- Ex-10.13 Employment Agreement, Chen Schor (Filed With SEC on November 9, 2006)
- Ex-10.14 Employment Agreement, Oren Becker, Ph.D (Filed With SEC on November 9, 2006)
- Ex-10.15 Employment Agreement, Stephen R. Donahue, M.D (Filed With SEC on November 9, 2006)
- EX-2.1 Agreement and Plan of Merger dated April 3, 2006 (Filed With SEC on April 3, 2006)
- EX-10.1 Form of Voting Agreement dated April 3, 2006 (Filed With SEC on April 3, 2006)
- EMPLOYMENTAGREEMENT (Filed With SEC on November 2, 2005)
- Severanceand Incentive Agreement (Filed With SEC on November 2, 2005)
- EPIX Pharmaceuticals, Inc. Named Executive Officers Bonus Awards and Plans (Filed With SEC on May 9, 2005)
- CONFIDENTIALTREATMENT EPIX Medical,Inc. has requested that the marked portions of this document be accordedconfidential treatment pursuant to Rule 24b-2 under the Securities... (Filed With SEC on August 3, 2004)
- EPIX MEDICAL, INC. ISSUER AND U.S. BANK NATIONALASSOCIATION, TRUSTEE INDENTURE Dated as ofJune 7, 2004 3% CONVERTIBLESENIOR NOTES DUE JUNE 15, 2024 EPIXMEDICAL, INC.... (Filed With SEC on June 7, 2004)
- EPIX MEDICAL, INC. $75,000,000 3% CONVERTIBLE SENIOR NOTES DUE 2024 PURCHASE AGREEMENT (Filed With SEC on June 7, 2004)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on June 7, 2004)
- STOCK PURCHASE AGREEMENT By and between EPIX MEDICAL, INC. And DR. MARTIN R. PRINCE Dated as of November 17, 2003 (Filed With SEC on November 18, 2003)
- THIRDAMENDMENT LEASE FROM TRUSTEES OFTHE CAMBRIDGE EAST TRUST TO EPIXMEDICAL, INC. (Filed With SEC on August 14, 2002)
